JP2007519747A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519747A5
JP2007519747A5 JP2006551554A JP2006551554A JP2007519747A5 JP 2007519747 A5 JP2007519747 A5 JP 2007519747A5 JP 2006551554 A JP2006551554 A JP 2006551554A JP 2006551554 A JP2006551554 A JP 2006551554A JP 2007519747 A5 JP2007519747 A5 JP 2007519747A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
piperacillin
pharmaceutically acceptable
tazobactam
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519747A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003048 external-priority patent/WO2005074925A1/en
Publication of JP2007519747A publication Critical patent/JP2007519747A/ja
Publication of JP2007519747A5 publication Critical patent/JP2007519747A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551554A 2004-01-30 2005-01-27 ピペラシリンおよびタゾバクタムを含みガラクトマンナンを実質的には含まない組成物 Withdrawn JP2007519747A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54091004P 2004-01-30 2004-01-30
PCT/US2005/003048 WO2005074925A1 (en) 2004-01-30 2005-01-27 Compositions substantially free of galactomannan containing piperacillin and tazobactam

Publications (2)

Publication Number Publication Date
JP2007519747A JP2007519747A (ja) 2007-07-19
JP2007519747A5 true JP2007519747A5 (enExample) 2008-03-13

Family

ID=34837439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551554A Withdrawn JP2007519747A (ja) 2004-01-30 2005-01-27 ピペラシリンおよびタゾバクタムを含みガラクトマンナンを実質的には含まない組成物

Country Status (7)

Country Link
US (1) US20050171077A1 (enExample)
EP (1) EP1711178A1 (enExample)
JP (1) JP2007519747A (enExample)
KR (1) KR20060127931A (enExample)
CN (1) CN1913890A (enExample)
CA (1) CA2553038A1 (enExample)
WO (1) WO2005074925A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787641A1 (de) * 2005-11-22 2007-05-23 Helm AG Tazobactam-Piperacillin-Lyophilisat
WO2007065862A1 (en) * 2005-12-05 2007-06-14 Sandoz Ag Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution
ITMI20070568A1 (it) * 2007-03-22 2008-09-23 Acs Dobfar Spa Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi
EP3616695B1 (en) 2011-09-09 2024-10-23 Merck Sharp & Dohme LLC Ceftolozane/tazobactam for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN103006676B (zh) * 2012-12-27 2015-02-25 石药集团中诺药业（石家庄）有限公司 新型哌拉西林他唑巴坦组合物
EP2893929B1 (en) 2013-03-15 2025-04-16 Merck Sharp & Dohme LLC Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534977A (en) * 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4477452A (en) * 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
AUPQ137699A0 (en) * 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
WO2004098643A1 (en) * 2003-04-14 2004-11-18 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection

Similar Documents

Publication Publication Date Title
JP2007519747A5 (enExample)
JP2019526628A5 (enExample)
JP2016535065A5 (enExample)
JP2012503489A5 (enExample)
JP2008509924A5 (enExample)
ME00556A (en) Freeze-dried pantoprazole preparation and pantoprazole injection
JP2013523677A5 (enExample)
HRP20141160T1 (hr) Kristali natrijevog lakvinimoda i postupak za njihovu proizvodnju
CN102863519B (zh) 一种盐酸万古霉素的精制方法
JP2015515968A5 (enExample)
JP2018514507A5 (enExample)
CN104825398B (zh) 表面介孔丝素蛋白微球药物缓释载体的制备方法及应用
CN106497791B (zh) 一种金黄色葡萄球菌冻干制备用新型复合保护剂
JP2016528233A5 (enExample)
Lin et al. The rough inhalable ciprofloxacin hydrochloride microparticles based on silk fibroin for non-cystic fibrosis bronchiectasis therapy with good biocompatibility
JP4319835B2 (ja) セフチオフルナトリウム塩の製造方法
CN103665074B (zh) 一种发酵液中纳他霉素的提取纯化方法
CN101433519B (zh) 阿奇霉素滴眼剂及其制备方法
CN102242173B (zh) 一种石斑鱼虹彩病毒囊膜蛋白的提取方法
CN1311815C (zh) 亚微米蜂胶微胶囊的制备方法
JPWO2020072601A5 (enExample)
JP2012501331A (ja) カンフォスファミド製剤及びその製造方法
CN1838943A (zh) 氟吡汀可注射盖伦剂型
US20150141630A1 (en) Process for preparation of iron sucrose
CN111803650B (zh) 酪胺-岩藻聚糖在预防病毒经黏膜传播中的应用及其制备方法、药剂